Urine| Hair Follicle | Oral Fluid | Blood | ETG
Hair analysis is increasingly recognized as an effective method for detecting drug and alcohol consumption. Hair serves as a chronological record for alcohol and other drugs by embedding biomarkers within the fibers of the growing strand. Sampling hair near the scalp offers a detection span of nearly 3 months for alcohol and other drugs. Hair collection is straightforward, relatively resistant to tampering, and convenient to transport.
A hair specimen of 1.5 inches comprising approximately 200 strands (similar to a #2 pencil) near the scalp is required to obtain 100mg of hair, which is optimal for screening and verification. For EtG or additional tests beyond 10 panels, 150mg is advised. It's suggested to weigh the sample using a jeweler's scale. If scalp hair is absent, a similar amount of body hair is an alternative. In terms of head hair, we specifically mean scalp hair. Body hair encompasses all other hair types (facial, axillary, etc.).
Process Overview
There are four primary phases in laboratory processing for drug test outcomes: Accessioning, Screening, Extraction, and Confirmation.
Accessioning involves the initial entry of a sample into the laboratory's system. This step includes ensuring the sample was properly sealed and shipped, issuing a random LAN (Laboratory Accessioning Number), and completing any extra data entry not available in an electronic chain of custody system.
Screening is an initial rapid check for abused drugs. Although Screening is economical for ruling out drug use in most samples, a positive screen must be confirmed for court validity. Samples with a presumptive positive in Screening require further confirmation.
When a sample indicates a presumptive positive result in the Screening step, additional hair is extracted from the original sample for the Extraction process. In this step, drugs are extracted from hair at a lower concentration than other methodologies (e.g., urine or oral fluid), making hair drug screening the most complex method to execute.
Confirmation of any positive screening result is accomplished via GC/MS, GC/MS/MS, or LC/MS/MS. Presumptive positive samples undergo washing prior to confirmation as necessary. The complete laboratory procedure from Accessioning to Confirmation is evaluated under the CAP (College of American Pathologists) Hair designation and accredited to ISO / IEC 17025 standards.
Advantages of hair drug testing:
Limitations:
Note: Although often termed "hair follicle tests," the test evaluates the hair strand rather than the follicle beneath the scalp.
When comparing hair follicle tests to traditional urine tests at Malmstrom AFB, MT, the advantages of the former are clear. Hair testing provides superior detection accuracy, offering a more dependable reflection of an individual's substance use. In contrast, urine tests often fall short in reliability over extended periods.
Hair follicle tests overshadow urine counterparts with their enhanced accuracy in detection. This elevated precision ensures a clearer picture of substance use, serving employers and legal systems better than conventional urine analyses.
The extended detection window of hair follicle tests enables a retrospective analysis of up to 90 days. This ability offers employers in Malmstrom AFB, MT, a comprehensive insight into the applicant or employee's drug use history. Such a broad detection period is integral for informed decision-making.
Employers benefit from the long detection threshold of hair testing, covering a substantial 90-day span. This feature ensures a thorough evaluation of substance history, unlike shorter detection windows of other testing methods.
Hair follicle tests drastically minimize sample tampering risks, providing a reliable testing solution in Malmstrom AFB, MT. This method reduces the chances of adulteration, ensuring test results are trustworthy and unquestionable.
With inherent tamper-resistant properties, hair testing stands out as a credible option. It offers undeniable integrity in results, mitigating concerns about sample manipulation.
At Malmstrom AFB, MT, our convenient network of nationwide testing centers simplifies access to drug testing services. This ease of accessibility ensures that tests are conducted quickly and without hassle.
Our broad geographical presence streamlines the testing process. Clients benefit from quick and efficient service, supported by strategically located centers throughout the nation.
The hair follicle testing process at Malmstrom AFB, MT, is straightforward and confidential. Our procedure ensures privacy concerns are addressed, making it easy for both ordering and receiving results.
A simplified approach to hair testing prioritizes confidentiality. This setup ensures individuals experience ease in every step, from test ordering through to result delivery.
Our hair follicle testing services in Malmstrom AFB, MT provide competitive pricing without compromising on quality. Quick turnaround times amplify the value, offering businesses peace of mind through cost-effective solutions.
Affordability meets efficiency with our testing services. Businesses receive rapid results while benefiting from a pricing structure that aligns with budgetary constraints.
At Malmstrom AFB, MT, hair follicle drug tests are synonymous with speed and precision. These tests stand out for their high accuracy in detecting substance use, providing reliable results. A meticulous methodology ensures fast processing, making it a preferred choice for urgent testing needs.
Employing advanced technology, our hair testing services guarantee rapid and precise outcomes. This efficiency makes it particularly appealing to employers and individuals requiring swift confirmation of drug use.
Adopting hair follicle testing ensures compliance with workplace drug-free policies in Malmstrom AFB, MT. This alignment reduces legal liabilities and bolsters workplace safety, offering peace of mind to employers.
The use of hair testing supports adherence to rigid drug policies, relieving legal pressures. Employers can maintain safe workplaces, lessening risks associated with non-compliance.
